Forest Neurotech is a brain-computer interface company focused on developing high-performance, fully implantable neural interfaces for restoring function in patients with neurological conditions. The company is working on next-generation BCI technology with a focus on accessibility and long-term reliability.
Forest Neurotech is a neurotechnology startup developing next-generation brain-computer interfaces with a focus on treating neurological and psychiatric disorders. The company aims to create minimally invasive, high-resolution neural interfaces that can be deployed at scale for clinical applications.
| Attribute |
Value |
| Focus |
Brain-computer interfaces, neural prosthetics |
| Stage |
Development stage, preclinical |
| Website |
forestneurotech.com |
| Year |
Round |
Amount |
| 2023 |
Seed |
$10 million |
| 2024 |
Series A |
$40 million |
Forest Array represents the company's core neural recording technology:
- High-density neural electrode array
- 1,000+ channel recording capability
- Designed for chronic implantation
- Biocompatible materials for long-term tissue integration
Custom micro-electrode arrays with enhanced biocompatibility:
- Minimally invasive cortical implants placed epidurally
- High-density array with 500+ channels for detailed neural recording
- Fully wireless system design eliminating external connectors
- Inductive charging or energy harvesting for continuous operation
Wireless data transmission system:
- High-bandwidth connectivity
- Real-time neural signal transmission
- Low-latency communication
- Real-time Decoding: Low-latency neural signal processing for responsive feedback
- AI/ML Models: Advanced machine learning for pattern recognition and signal classification
- Adaptive Systems: Self-adjusting algorithms that respond to neural changes over time
Forest Neurotech's approach includes:
- High-Density Arrays: More electrodes than existing systems (500-1000+ channels)
- Biocompatible Materials: Long-term tissue compatibility
- Wireless Power: No batteries requiring replacement
- Advanced Decoding: Machine learning for signal interpretation
- Minimally Invasive: Reduced surgical risk compared to fully invasive options
- Fully Wireless: Eliminating external connectors for patient comfort
| Program |
Indication |
Stage |
| BCI Development |
Neural interfaces |
Preclinical |
| Memory and Cognition |
Alzheimer's disease |
Research |
| Movement Decoding |
Parkinson's disease |
Research |
| Communication Interfaces |
ALS, stroke |
Research |
| Mood Regulation |
Treatment-resistant depression |
Research |
| Seizure Control |
Epilepsy |
Research |
- Restoring speech and text communication
- Text generation from neural signals
- Augmentative and alternative communication (AAC) integration
- Controlling wheelchairs and prosthetics
- Cursor control for computer access
- Robotic limb control
- Restoring movement for paralysis patients
- Brain-controlled robotics
- Rehabilitation assistance
- Providing artificial sensory feedback
- Haptic feedback integration
- Sensory substitution
- Memory circuit mapping and modulation for cognitive preservation
- Cognitive function monitoring through continuous neural assessment
- Targeted neuromodulation for memory enhancement
- Early detection of cognitive decline
- Movement state decoding for adaptive treatment
- Adaptive deep brain stimulation integration
- Tremor prediction and suppression systems
- Monitoring disease progression
- Communication interfaces for locked-in patients
- Respiratory function monitoring
- Quality of life enhancement
- Limbic system monitoring and mapping
- Targeted stimulation protocols for mood regulation
- Closed-loop treatment systems responding to neural markers
- Early seizure detection through neural pattern analysis
- Predictive algorithms for seizure forecasting
- Responsive neurostimulation for seizure prevention
Forest is developing technology that addresses limitations of current BCIs:
- Longevity: Arrays designed for decades of use without degradation
- Bandwidth: Higher channel counts for richer control signals
- Safety: Rigorous testing for chronic implantation
- Accessibility: Lower barriers to adoption and cost
- Miniaturization: Smaller device footprints
- Power Efficiency: Extended battery life and wireless charging
- Dr. Peter H. (CEO and Co-founder)
- Dr. Sarah M. (Co-founder and CSO)
- Dr. Richard T. (CTO)
¶ Competitive Landscape
Forest Neurotech competes with leading BCI companies:
| Company |
Approach |
Invasiveness |
Channel Count |
| Forest Neurotech |
Minimally invasive |
Epidural |
500-1000+ |
| Neuralink |
Fully invasive |
Intra-cortical |
1,024 |
| Synchron |
Minimally invasive |
Stent-based |
16 |
| Paradromics |
Fully invasive |
Intra-cortical |
1,024+ |
| Blackrock Neurotech |
Fully invasive |
Utah array |
96-256 |
- Focus on reliability and longevity
- Academic collaboration emphasis
- Cost-effective manufacturing
- Minimally invasive approach
- Wireless design
- Focus on medical applications
Forest's technology captures neural activity through:
- Microelectrode arrays detecting action potentials
- Local field potentials (LFPs) for network activity
- Electrocorticography (ECoG) for high-resolution recording
Machine learning algorithms translate neural signals:
- Pattern recognition for movement intention
- Natural language processing for speech decoding
- Cognitive state classification
- Motor cortex: Movement control
- Somatosensory cortex: Sensory feedback
- Hippocampus: Memory formation
- Prefrontal cortex: Decision-making
Forest Neurotech's BCI technology interfaces with several key neurodegenerative disease mechanisms: